Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients
NCT01415011
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG:
Afatinib (BIBW 2992)
Sponsor
University College, London
Collaborators
[object Object]